These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38682016)
1. Correction to "the effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography". Ibrain; 2024; 10(1):116. PubMed ID: 38682016 [TBL] [Abstract][Full Text] [Related]
2. The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography. Tan DD; Gu J; Li J; Yu WQ; Liu DX; Zhao LJ; Zhu GH; Yang XX; Tian J; Tian Q; Zhu ZQ Ibrain; 2023; 9(3):290-297. PubMed ID: 37786755 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial. Deng Y; Qin Z; Wu Q; Liu L; Yang X; Ju X; Zhang Y; Liu L Drug Des Devel Ther; 2022; 16():2439-2451. PubMed ID: 35937566 [TBL] [Abstract][Full Text] [Related]
4. Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study. Chen X; Zhang J; Yuan S; Huang H Sci Rep; 2022 Nov; 12(1):19022. PubMed ID: 36347892 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 95% effective dose of remimazolam besylate and propofol for gastroscopy sedation on older patients: A single-centre randomized controlled trial. Ye E; Wu K; Ye H; Zhang W; Chu L; Zhang K; Xie G; Jin Y; Fang X Br J Clin Pharmacol; 2023 Nov; 89(11):3401-3410. PubMed ID: 37387195 [TBL] [Abstract][Full Text] [Related]
6. Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction. Lu Z; Zhou N; Li Y; Yang L; Hao W Ann Palliat Med; 2022 Feb; 11(2):568-573. PubMed ID: 35249335 [TBL] [Abstract][Full Text] [Related]
7. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures. Dong SA; Guo Y; Liu SS; Wu LL; Wu LN; Song K; Wang JH; Chen HR; Li WZ; Li HX; Zhang L; Yu JB J Clin Anesth; 2023 Jun; 86():111077. PubMed ID: 36764022 [TBL] [Abstract][Full Text] [Related]
9. Finding the ideal sedative: a non-inferiority study of remimazolam vs propofol in endoscopic retrograde cholangiopancreatography. Lee J; Jeong S; Lee DH; Park JS J Gastroenterol Hepatol; 2023 Dec; 38(12):2160-2166. PubMed ID: 37730240 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial. Wang X; Hu X; Bai N; Li L; Zhang M; Cheng Z; Guo Q Front Pharmacol; 2022; 13():900723. PubMed ID: 36278187 [No Abstract] [Full Text] [Related]
11. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Tang Y; Yang X; Yu Y; Shu H; Yuan Y; Liu H; Zou X; Yuan S; Shang Y Crit Care; 2022 Sep; 26(1):279. PubMed ID: 36114552 [TBL] [Abstract][Full Text] [Related]
12. Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study. Tang Y; Gao X; Xu J; Ren L; Qi H; Li R; Shu H; Zou X; Yuan S; Yang X; Shang Y Crit Care; 2023 Dec; 27(1):474. PubMed ID: 38049909 [TBL] [Abstract][Full Text] [Related]
13. Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial. Yang X; Tang Y; Du R; Yu Y; Xu J; Zhang J; Liu H; Zou X; Ren L; Yuan S; Shang Y Front Pharmacol; 2023; 14():1139872. PubMed ID: 37576823 [No Abstract] [Full Text] [Related]
14. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies. Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319 [TBL] [Abstract][Full Text] [Related]
15. Remimazolam: A Review in Procedural Sedation. Lee A; Shirley M Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946 [TBL] [Abstract][Full Text] [Related]
16. Remimazolam for a patient with myotonic dystrophy type 1 who underwent endoscopic retrograde cholangiopancreatography under general anesthesia: a case report. Fukuda M; Tachibana S; Nishihara N; Yamakage M JA Clin Rep; 2021 Feb; 7(1):17. PubMed ID: 33625620 [TBL] [Abstract][Full Text] [Related]
17. Erratum: Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]. Drug Des Devel Ther; 2022; 16():2681-2682. PubMed ID: 35978858 [TBL] [Abstract][Full Text] [Related]
18. A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation. Zhou J; Curd L; Lohmer LRL; Delpratt N; Ossig J; Schippers F; Stoehr T; Schmith VD Clin Transl Sci; 2021 Jul; 14(4):1554-1565. PubMed ID: 33768731 [TBL] [Abstract][Full Text] [Related]
19. Remimazolam: A Retrospective Study of Initial Safety and Recovery Data in Diverse Procedural Sedation. Johnson KL; Meyers JS; Mortensen GN; Steege JR; Mara KC; Brinkman NJ Clin Ther; 2024 Feb; 46(2):90-95. PubMed ID: 38071132 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of remimazolam besylate in bronchoscopy for adults: A multicenter, randomized, double-blind, positive-controlled clinical study. Zhou YY; Yang ST; Duan KM; Bai ZH; Feng YF; Guo QL; Cheng ZG; Wu H; Shangguan WN; Wu XM; Wang CH; Chai XQ; Xu GH; Liu CM; Zhao GF; Chen C; Gao BA; Li LE; Zhang M; Ouyang W; Wang SY Front Pharmacol; 2022; 13():1005367. PubMed ID: 36313321 [No Abstract] [Full Text] [Related] [Next] [New Search]